Hartmann A, Andrén P, Atkinson-Clément C, Czernecki V, Delorme C, Monique Debes NM et al (2023) Tourette syndrome research highlights from 2022. F1000Res 12:826
Article CAS PubMed PubMed Central Google Scholar
Eddy CM, Rickards HE, Cavanna AE (2011) Treatment strategies for tics in Tourette syndrome. Ther Adv Neurol Disord 4(1):25–45
Article CAS PubMed PubMed Central Google Scholar
Seideman MF, Seideman TA (2020) A review of the current treatment of Tourette syndrome. J Pediatr Pharmacol Ther 25(5):401–412
PubMed PubMed Central Google Scholar
American Psychiatric Association. Diagnostic and statistical manual of mental disorders [Internet]. Fifth Edition. American Psychiatric Association; 2013 [cited 2023 Dec 25]. Available from: https://doi.org/10.1176/appi.books.9780890425596
Knight T, Steeves T, Day L, Lowerison M, Jette N, Pringsheim T (2012) Prevalence of tic disorders: A systematic review and meta-analysis. Pediatr Neurol 47(2):77–90
Jafari F, Abbasi P, Rahmati M, Hodhodi T, Kazeminia M (2022) Systematic review and meta-analysis of Tourette syndrome prevalence; 1986 to 2022. Pediatr Neurol 137:6–16
Charania SN, Danielson ML, Claussen AH, Lebrun-Harris LA, Kaminski JW, Bitsko RH (2022) Bullying victimization and perpetration among US children with and without Tourette syndrome. J Dev Behav Pediatr 43(1):23–31
Article PubMed PubMed Central Google Scholar
Scharf JM, Miller LL, Gauvin CA, Alabiso J, Mathews CA, Ben-Shlomo Y (2015) Population prevalence of Tourette syndrome: A systematic review and meta-analysis. Mov Disord 30(2):221–228
Hartmann A, Szejko N, Mol Debes N, Cavanna AE, Müller-Vahl K (2021) Is Tourette syndrome a rare condition? F1000Res 10:434
PubMed PubMed Central Google Scholar
Chadehumbe MA, Brown LW (2019) Advances in the treatment of Tourette’s disorder. Curr Psychiatry Rep 21(5):31
Leckman JF, Bloch MH, Smith ME, Larabi D, Hampson M (2010) Neurobiological substrates of Tourette’s disorder. J Child Adolesc Psychopharmacol 20(4):237–247
Article PubMed PubMed Central Google Scholar
Pringsheim T, Okun MS, Müller-Vahl K, Martino D, Jankovic J, Cavanna AE et al (2019) Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 92(19):896–906
Article PubMed PubMed Central Google Scholar
CDC. Centers for Disease Control and Prevention. 2023 [cited 2023 Dec 23]. Tourette Syndrome treatments | CDC. Available from: https://www.cdc.gov/ncbddd/tourette/treatments.html
Billnitzer A, Jankovic J (2020) Current management of tics and Tourette syndrome: Behavioral, pharmacologic, and surgical treatments. Neurotherapeutics 17(4):1681–1693
Article PubMed PubMed Central Google Scholar
Qasaymeh MM, Mink JW (2006) New treatments for tic disorders. Curr Treat Options Neurol 8(6):465–473
Piscura MK, Henderson-Redmond AN, Barnes RC, Mitra S, Guindon J, Morgan DJ (2023) Mechanisms of cannabinoid tolerance. Biochem Pharmacol 1(214):115665
Bodine M, Kemp AK. Medical cannabis use in oncology. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Mar 17]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK572067/
Lu HC, Mackie K (2016) An introduction to the endogenous cannabinoid system. Biol Psychiatry 79(7):516–525
Article CAS PubMed Google Scholar
Parrella NF, Hill AT, Enticott PG, Barhoun P, Bower IS, Ford TC (2023) A systematic review of cannabidiol trials in neurodevelopmental disorders. Pharmacol Biochem Behav 230:173607
Article CAS PubMed Google Scholar
Kluger BM, Huang AP, Miyasaki JM (2022) Cannabinoids in movement disorders. Parkinsonism Relat Disord 1(102):124–130
LJ Rice L Cannon N Dadlani MMY Cheung SL Einfeld D Efron Efficacy of cannabinoids in neurodevelopmental and neuropsychiatric disorders among children and adolescents: A systematic review. Eur Child Adolesc Psychiatry [Internet]. et al 2023 cited 2023 Dec 23 Available from: https://doi.org/10.1007/s00787-023-02169-w
Efron D, Taylor K (2023) Medicinal cannabis for paediatric developmental, behaviouralW and mental health disorders. Int J Environ Res Public Health 20(8):5430
Article CAS PubMed PubMed Central Google Scholar
Müller-Vahl KR, Schneider U, Prevedel H, Theloe K, Kolbe H, Daldrup T et al (2003) Delta 9-tetrahydrocannabinol (THC) is effective in the treatment of tics in Tourette syndrome: A 6-week randomized trial. J Clin Psychiatry 64(4):459–465
Müller-Vahl KR, Schneider U, Kolbe H, Emrich HM (1999) Treatment of Tourette’s syndrome with delta-9-tetrahydrocannabinol. Am J Psychiatry 156(3):495
Müller-Vahl KR, Schneider U, Koblenz A, Jöbges M, Kolbe H, Daldrup T et al (2002) Treatment of Tourette’s syndrome with Delta 9-tetrahydrocannabinol (THC): A randomized crossover trial. Pharmacopsychiatry 35(2):57–61
Müller-Vahl KR, Koblenz A, Jöbges M, Kolbe H, Emrich HM, Schneider U (2001) Influence of treatment of Tourette syndrome with delta9-tetrahydrocannabinol (delta9-THC) on neuropsychological performance. Pharmacopsychiatry 34(1):19–24
Pichler EM, Kawohl W, Seifritz E, Roser P (2019) Pure delta-9-tetrahydrocannabinol and its combination with cannabidiol in treatment-resistant Tourette syndrome: A case report. Int J Psychiatry Med 54(2):150–156
Thaler A, Arad S, Schleider LBL, Knaani J, Taichman T, Giladi N et al (2019) Single center experience with medical cannabis in Gilles de la Tourette syndrome. Parkinsonism Relat Disord 61:211–213
Anis S, Zalomek C, Korczyn AD, Lassman S, Rosenberg A, Gurevich T (2023) Licensed medical cannabis use in Gilles de la Tourette syndrome: A retrospective long-term follow-up. Cannabis Cannabinoid Res
Abi-Jaoude E, Bhikram T, Parveen F, Levenbach J, Lafreniere-Roula M, Sandor P (2023) A double-blind, randomized, controlled crossover trial of cannabis in adults with Tourette syndrome. Cannabis Cannabinoid Res 8(5):835–845
Article CAS PubMed Google Scholar
Lynch ME, Ware MA (2015) Cannabinoids for the treatment of chronic non-cancer pain: An updated systematic review of randomized controlled trials. J Neuroimmune Pharmacol 10(2):293–301
Article CAS PubMed Google Scholar
The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research [Internet]. Washington, D.C.: National Academies Press; 2017 [cited 2024 May 14]. Available from: https://www.nap.edu/catalog/24625
Roila F, Molassiotis A, Herrstedt J, Aapro M, Gralla RJ, Bruera E et al (2016) 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Ann Oncol 1(27):v119–v133
Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL (2017) Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American academy of sleep medicine clinical practice guideline. J Clin Sleep Med 13(02):307–349
Article PubMed PubMed Central Google Scholar
Babson KA, Sottile J, Morabito D (2017) Cannabis, cannabinoids, and sleep: A review of the literature. Curr Psychiatry Rep 19(4):23
Müller-Vahl KR (2024) Cannabinoids in the treatment of selected mental illnesses: Practical approach and overview of the literature. Pharmacopsychiatry 57(3):104–114
Article PubMed PubMed Central Google Scholar
Szejko N, Saramak K, Lombroso A, Müller-Vahl K (2022) Cannabis-based medicine in treatment of patients with Gilles de la Tourette syndrome. Neurol Neurochir Pol 56(1):28–38
Szejko N, Müller-Vahl KR. Chapter 37 - Medical use of cannabis: applications to Tourette syndrome. In: Preedy VR, Patel VB, Martin CR, editors. Medicinal Usage of Cannabis and Cannabinoids [Internet]. Academic Press; 2023 [cited 2024 May 14]. p. 457–71. Available from:
留言 (0)